BetterLife Pharma CEO Dr. Ahmad Doroudian and Senior Researcher at the Laboratory of Antiepileptic Drug Discovery in Indianapolis, Indiana, Jeff Witkin, Ph.D., joined Steve Darling from Proactive for our third episode of the series "The Business of Psychedelics". Both Doroudian and Witkin talk about the science behind psychedelics and what has been discovered so far and what is still to come. Witkin also talked about what he sees as very exciting work with psychedelics and what they can do to treat mental and physical health challenges.
Betterlife Pharma The Business of Psychedelics: Episode 3
